Clinical trial CADPT01C12101
A Phase Ib multicenter, open-label dose escalation and expansion platform study of selected drug combinations in adult patients with advanced or metastatic BRAF V600 colorectal cancer
| Cancers | |
|---|---|
| Organ | Colon |
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | Novartis |
| EudraCT Identifier | 2019-004688-27 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04294160 |
| Last update |